1. Post-i 60-km Race Illness Rates and Decreases in Granulocyte Respiratory Burst and Salivary IgA Output are Not Countered by Quercetin Ingestion.
- Author
-
Henson, D., Nieman, D., Davis, J. M., Dumke, C., Gross, S., Murphy, A., Carmichael, M., Jenkins, D. P., Quindry, J., McAnulty, S., McAnulty, L., Utter, A., and Mayer, E.
- Subjects
RESPIRATORY infections ,IMMUNOLOGY ,ATHLETES ,RUNNERS (Sports) ,MARATHON running ,LONG-distance runners ,IMMUNOGLOBULIN A ,PLACEBOS ,QUERCETIN ,FLAVONOIDS ,KILLER cells ,DIAGNOSIS ,PHYSIOLOGY ,HEALTH - Abstract
This study measured the influence of the flavonoid quercetin on immune changes and incidence rates of upper respiratory tract infections in ultramarathoners competing in the 160-km Western States Endurance Run. Sixty-three runners were randomized to quercetin and placebo groups, and under double-blinded methods ingested 1000 mg/day quercetin for 3 wks before, during, and 2 wks after the race. Thirty-nine of the 63 subjects (n = 18 for quercetin, n = 21 for placebo) finished the race and provided blood and saliva samples the morning before the race and 15-30mm postrace. Upper respiratory tract infections were assessed during the week before and the 2-wk period after the race using an illness symptom checklist. Race times did not differ significantly between quercetin and placebo groups. Significant pre- to postrace decreases were measured for natural killer cells (43%), granulocyte respiratory burst activity (55%), and salivary IgA output (48%), and increases for neutrophil(288%) and monocyte (211%) cell counts, with no significant group differences. Postrace illness rates did not differ between groups. In conclusion, quercetin supplementation for 3 wks before and 2 wks after the Western States Endurance Run had no effect on illness rates, perturbations in leukocyte subset counts, or decreases in granulocyte respiratory burst activity and salivary IgA. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF